Preferred Physical Characteristics of Vaginal Film Microbicides for HIV Prevention in Pittsburgh Women

Arch Sex Behav. 2017 May;46(4):1111-1119. doi: 10.1007/s10508-016-0816-1. Epub 2016 Aug 29.

Abstract

Unprotected heterosexual intercourse is the leading cause of HIV acquisition in women. Due to the complex nature of correct and consistent condom use by both men and women, developing alternative female-controlled HIV prevention options is a global health priority. Vaginal films containing antiretroviral drugs are a potential delivery system for the prevention of HIV acquisition through sexual contact. In this study, we explored women's preferences regarding physical characteristics of microbicide vaginal films through questionnaires and focus groups. Eighty-four sexually active, ethnically diverse women 18-30 years of age from Pittsburgh, Pennsylvania, participated in the study. Women visually and manually examined a variety of vaginal films, as well as three other vaginal products undergoing evaluation for HIV prevention: tablet, ring, and gel. Means and standard deviations or frequencies and 95 % confidence intervals were calculated for questionnaire data. Focus groups were audio-recorded, transcribed verbatim, and coded for content analysis. Women most frequently preferred vaginal films to be smooth and thin (63 %), translucent (48 %), and 2″ × 2″ square size (36 %). Driving these preferences were five major themes: ease and accuracy of use, desire for efficacy, discretion, intravaginal comfort and minimal impact, and minimizing disruption of sexual mood/activities. Women's preferences for various microbicide vaginal film physical attributes represented a balance of multiple values. In general, women desired a comfortable, efficacious, easy to use, and minimally intrusive product.

Keywords: HIV prevention; Microbicide acceptability; Vaginal film; Women.

MeSH terms

  • Administration, Intravaginal
  • Anti-Infective Agents* / administration & dosage
  • Anti-Infective Agents* / therapeutic use
  • Female
  • HIV Infections / prevention & control*
  • Humans
  • Patient Preference* / psychology
  • Patient Preference* / statistics & numerical data
  • Pennsylvania
  • Vaginal Creams, Foams, and Jellies* / administration & dosage
  • Vaginal Creams, Foams, and Jellies* / therapeutic use

Substances

  • Anti-Infective Agents
  • Vaginal Creams, Foams, and Jellies